We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

32 hedge funds and large institutions have $1.52M invested in NKGen Biotech, Inc. Warrants in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

9% less funds holding

Funds holding: 35 → 32 (-3)

11% less capital invested

Capital invested by funds: $1.72M → $1.52M (-$197K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
4
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$31.6K
2
RCM
Rivernorth Capital Management
Florida
+$21.3K
3
GF
Gabelli Funds
New York
+$6.88K
4
SCM
Saba Capital Management
New York
+$5.36K

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$8.75K
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$7K
3
VCIM
Velan Capital Investment Management
Georgia
-$5K
4
KC
Kepos Capital
New York
-$4.3K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.17M – – –
HCM
2
Highbridge Capital Management
New York
$43K – – –
MF
3
Magnetar Financial
Illinois
$29K +$31.6K +183,880 +1,141%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$27K – – –
RCM
5
Rivernorth Capital Management
Florida
$24K +$21.3K +123,753 +315%
AA
6
AQR Arbitrage
Connecticut
$20K – – –
PC
7
Periscope Capital
Ontario, Canada
$18K – – –
DCM
8
Difesa Capital Management
New York
$17K – – –
6CM
9
683 Capital Management
New York
$15K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
10
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$15K – – –
KL
11
KIM LLC
Kansas
$13K – – –
KC
12
Kepos Capital
New York
$12K -$4.3K -25,000 -24%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$12K – – –
PSAMP
14
P. Schoenfeld Asset Management (PSAM)
New York
$12K – – –
TCA
15
Taconic Capital Advisors
New York
$11K – – –
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$9K – – –
GF
17
Gabelli Funds
New York
$9K +$6.88K +40,000 +199%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$8K – – –
FBCM
19
Fort Baker Capital Management
California
$8K – – –
SCM
20
Shaolin Capital Management
Florida
$8K – – –
FTCM
21
Fir Tree Capital Management
New York
$7K -$8.75K -50,840 -51%
AIMCA
22
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$6K – – –
ACM
23
Atalaya Capital Management
New York
$5K – – –
SCM
24
Saba Capital Management
New York
$5K +$5.36K +31,129 New
JG
25
Jefferies Group
New York
$3.85K – – –
1
2

NKGNW Hedge Fund Activity: Q3 2022 in Review

32 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2022, worth a combined $1.52M — down 11% from $1.72M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NKGNW and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Magnetar Financial, adding an estimated $31.6K. The largest seller was Fir Tree Capital Management, cutting an estimated $8.75K.

  • 32 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2022, down from 35 in Q2 2022.
  • Funds reported $1.52M of NKGen Biotech, Inc. Warrants stock for Q3 2022, down 11% quarter-over-quarter.
  • 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q3 2022 and 4 closed out, a net change of -3 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q3 2022 was Magnetar Financial, an estimated $31.6K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q3 2022 was Fir Tree Capital Management, an estimated $8.75K sold.

Based on aggregated 13F filings for Q3 2022.